Virtual Incision Completes FDA Investigational Device Exemption Clinical Study for MIRA
February 24, 2023
Virtual Incision claimed that it was the first robot-assisted surgical developer to complete a study to support a De Novo request for MIRA to conduct bowel resection procedures.
Virtual Incision’s MIRA Surgical Robot to Show Skills on International Space Station
August 10, 2022
Virtual Incision said its MIRA miniaturized robot-assisted surgical device will demonstrate the potential for greater access to surgical care on Earth and beyond.
Virtual Incision Gets OK From FDA for Clinical Studies on Bowel Resection Procedures
April 19, 2022
Virtual Incision announced that the FDA has granted it an Investigational Device Exemption to complete research on how its robot-assisted surgery platform can aid bowel resection procedures.
Virtual Incision Obtains Series C Funding for MIRA Robotic Surgical System
November 30, 2021
The MIRA surgical platform, which Virtual Incision says is the first miniaturized robot of its kind, is currently in clinical studies as the company gets financing for commercialization.
Virtual Incision’s MIRA Miniature Robotic System Assists in Its First Surgical Procedure at Bryan Medical Center
August 16, 2021
On its path to commercialization, Virtual Incision has participated in the first procedure using its MIRA miniature robotic surgical system under an FDA IDE exemption.
